Vivos Therapeutics, Inc.
VVOS- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001716166
No open-market purchases or sales by Vivos Therapeutics, Inc. insiders were filed in the last 90 days; 22 institutions reported holding it in 13F filings for Q2 2026, worth $242.7K in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Vivos Therapeutics, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 29
- −8 vs. Q3 2021
- Shares held
- 2.23M
- −29.6K (−1.3%) vs. Q3 2021
- Total value
- $5.02M
- −$4.12M (−45.1%) vs. Q3 2021
- New holders
- 3
- 9 more added
- Sold out
- 11
- 11 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VVOS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 22 | $242.7K |
| Q1 2026 | 25 | $2.15M |
| Q4 2025 | 20 | $1.34M |
| Q3 2025 | 23 | $2.13M |
| Q2 2025 | 19 | $1.27M |
| Q1 2025 | 21 | $1.00M |
| Q4 2024 | 20 | $2.00M |
| Q3 2024 | 23 | $630.7K |
| Q2 2024 | 19 | $433.8K |
| Q1 2024 | 16 | $646.8K |
| Q4 2023 | 18 | $3.12M |
| Q3 2023 | 28 | $860.6K |
| Q2 2023 | 31 | $2.39M |
| Q1 2023 | 30 | $1.71M |
| Q4 2022 | 27 | $629.7K |
| Q3 2022 | 30 | $1.38M |
| Q2 2022 | 28 | $2.82M |
| Q1 2022 | 28 | $6.66M |
| Q4 2021 | 29 | $5.02M |
| Q3 2021 | 37 | $9.14M |
| Q2 2021 | 29 | $11.7M |
| Q1 2021 | 18 | $5.45M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Vivos Therapeutics, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 663,253 | $1.49M | 0.00% | +46,002+7.5% | Added |
| Russell Investments Group, Ltd. | 305,096 | $684.0K | 0.00% | +258,445+554.0% | Added |
| Bard Associates Inc | 213,502 | $480.0K | 0.16% | −1,998−0.9% | Reduced |
| Perkins Capital Management Inc | 136,050 | $306.0K | 0.21% | −10,450−7.1% | Reduced |
| Anson Funds Management LP | 122,297 | $275.0K | 0.04% | +122,297 | New |
| Two Sigma Investments, LP | 117,215 | $264.0K | 0.00% | −40,109−25.5% | Reduced |
| Geode Capital Management, LLC | 111,463 | $250.0K | 0.00% | +37,612+50.9% | Added |
| Boston Partners | 108,015 | $243.0K | 0.00% | +61,364+131.5% | Added |
| National Asset Management, Inc. | 79,270 | $179.0K | 0.01% | +28,283+55.5% | Added |
| Susquehanna International Group, LLP | 66,319 | $150.0K | 0.00% | +11,416+20.8% | Added |
| Credit Agricole S A | 59,103 | $133.0K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 50,448 | $114.0K | 0.00% | +1,543+3.2% | Added |
| Griffin Asset Management, Inc. | 43,000 | $97.0K | 0.01% | −6,500−13.1% | Reduced |
| Northern Trust Corp | 40,604 | $91.0K | 0.00% | −423−1.0% | Reduced |
| Citadel Advisors LLC | 26,063 | $59.0K | 0.00% | −53,056−67.1% | Reduced |
| Cambridge Investment Research Advisors, Inc. | 19,200 | $43.0K | 0.00% | +7,200+60.0% | Added |
| State Street Corp | 18,233 | $41.0K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 17,083 | $38.0K | 0.00% | +14,188+490.1% | Added |
| Avalon Investment & Advisory | 15,269 | $34.0K | 0.00% | −314,053−95.4% | Reduced |
| Tower Research Capital LLC (TRC) | 5,443 | $12.0K | 0.00% | −32,188−85.5% | Reduced |
| Group One Trading, L.P. | 4,563 | $10.0K | 0.00% | −2,773−37.8% | Reduced |
| Rockefeller Capital Management L.P. | 3,500 | $7.00K | 0.00% | 00.0% | Unchanged |
| Stephens Consulting, LLC | 3,000 | $6.75K | 0.01% | +3,000 | New |
| Morgan Stanley | 2,401 | $5.00K | 0.00% | −129−5.1% | Reduced |
| Wells Fargo & Company | 2,109 | $5.00K | 0.00% | 00.0% | Unchanged |
| Kozak & Associates, Inc. | 1,205 | $4.00K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 141 | $0 | 0.00% | −537−79.2% | Reduced |
| Toth Financial Advisory Corp | 200 | $0 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 26 | $0 | 0.00% | +26 | New |
| Virtu Financial LLC | 0 | $0 | 0.00% | −35,334−100.0% | Sold out |
| Aperture Investors, LLC | 0 | $0 | 0.00% | −35,276−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −34,443−100.0% | Sold out |
| Blueshift Asset Management, LLC | 0 | $0 | 0.00% | −18,826−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −14,999−100.0% | Sold out |
| WMS Partners, LLC | 0 | $0 | 0.00% | −12,167−100.0% | Sold out |
| Financial Management Professionals, Inc. | 0 | $0 | 0.00% | −5,897−100.0% | Sold out |
| Cutler Group LP | 0 | $0 | 0.00% | −501−100.0% | Sold out |
| Global Retirement Partners, LLC | 0 | $0 | 0.00% | −570−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −480−100.0% | Sold out |
| Wagner Wealth Management, LLC | 0 | $0 | 0.00% | −275−100.0% | Sold out |